$100 Invested In Alnylam Pharmaceuticals 15 Years Ago Would Be Worth This Much Today

What’s in the new US-UK trade deal? How will Trump’s tariffs impact carmakers? Why was Celsius founder sentenced to prison? What caused Bitcoin to surge past $100,000? How is Meta re-entering the stablecoin market? Why did the Federal Reserve hold interest rates? How did the UK rate cut respond to trade tensions? What’s behind Peloton’s latest revenue forecast rise? Why are companies passing tariffs costs to consumers?

$100 Invested In Alnylam Pharmaceuticals 15 Years Ago Would Be Worth This Much Today

benzinga.com/insights/news/25/05/45305113/100-invested-in-alnylam-pharmaceuticals-15-years-ago-would-be-worth-this-much-today

Alnylam Pharmaceuticals (NASDAQ:ALNY) has outperformed the market over the past 15 years by 8.93% on an annualized basis producing an average annual return of 20.2%. Currently, Alnylam Pharmaceuticals has a market capitalization of $33.44 billion.
Buying $100 In ALNY: If ...
Full story…

This story appeared on benzinga.com, 2025-05-08 22:30:16.